Immunopathological mechanisms of eosinophilic esophagitis;Mecanismos inmunopatológicos de la esofagitis eosinofílica

Allergologia et Immunopathologia

Volumn 36, Issue SUPPL. 1, 2008, Pages 17-19

  Lucendo Villarin A J ^a  

^a HOSPITAL GENERAL LA MANCHA CENTRO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E; INTERLEUKIN 5;

ALLERGIC REACTION; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; COLITIS; CONFERENCE PAPER; DENDRITIC CELL; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; EOSINOPHILIC ESOPHAGITIS; ESOPHAGUS MUCOSA; GASTROENTERITIS; HUMAN; HYPERSENSITIVITY; IMMUNOPATHOLOGY; LANGERHANS CELL; LYMPHOCYTIC INFILTRATION; MAST CELL; NATURAL KILLER T CELL; PATHOGENESIS; TH2 CELL;

EID: 48749115416     PISSN: 03010546     EISSN: 15781267     Source Type: Journal    
DOI: 10.1157/13115666     Document Type: Conference Paper

References (151)

1. Atwood SE, Smyrk TC, Demeester TR, Jones JB. Esophageal eosinophilia with dysphagia. A distinct clinicopathologic syndrome. Dig Dis Sci. 1993;38:109-16.
2. Lucendo AJ, Carrión G, Navarro M, Pascual JM, Gonzalez P, Castillo P et al. Eosinopilic esophagitis in adults: an emerging disease. Dig Dis Sci. 2004;49:1884-8.
3. Nielsen RJ, Husby S. Eosinophilic oesophagitis: epidemiology, clinical aspects, and association to allergy. J Pediatr Gastroenterol Nutr. 2007;45:281-9.
4. Markowitz JE, Liacouras CA. Eosinophilic esophagitis. Gastroenterology Clin North Am. 2003;32:949-66.
5. Picus D, Frank P. Eosinophilic esophagitis. Am J Roentgenol. 1981;136:1001-3.
6. Rothenberg ME. Eosinophilic gastrointestinal disorders. J Allergy Clin Inmunol. 2004;113:11-28.
7. Lucendo AJ. Esofagitis eosinofílica. Med Clin (Barc). 2007;128:590-7.
8. De Keyser F, Elewaut D, De Wever N, Bensbaho K, Cuvelier C. The gut associated addressins: Linphocyte homing in the gut. Baillieres Clin Rheumatol. 1996;10:25-39.
9. MacDonal TT, Pender SL. Lamina propria T cells. Chem Immunol. 1998;71:103-17.
10. MacDonal TT, Bajaj-Elliott M, and Pender SL. T cells orchestrate intestinal mucosal shape and integrity. Immunol Today. 1999;20:505-10.
11. Muñoz-López F. Validity of the hygiene hypothesis. Allergol Inmunopathol (Madr). 2006;34:129-30.
12. Murch SH. Clinical manifestations of food allergy: the old and the new. Eur J Gastroenterol Hepatol. 2005;17:1287-91.
13. De Angelis P, Markowitz JE, Torroni F, Caldaro T, Pane A, Morino G et al Paediatric eosinophilic oesophagitis: Towards early diagnosis and best treatment. Dig Liver Dis. 2006;38:245-51.
14. Heine RG. Pathophysiology, diagnosis and treatment of food protein-induced gastrointestinal diseases. Curr Opin Allergy Clin Immunol. 2004;4:221-9.
15. Sánchez-Fayos Calabuig P, Martín Reyoso MJ, González Guirado A, Porres Cubero JC. Los granulocitos eosinófilos: de residentes habituales de la mucosa gastrointestinal normal a protagonistas agresivos de la gastroenteritis eosinofílica. Gastroenterol Hepatol. 2006;29:352-7.
16. Moneret-Vautrin AD. Gastrointestinal allergy in adults. Eur J Gastroenterol Hepatol. 2005;17:1293-7.
17. Torpier G, Colombel JF, Mathieu-Chandelier C, Capron M, Dessaint JP, Cortot A et al. Eosinophilic gastroenteritis: ultrastructural evidence for a selective release of eosinophil major basic protein. Clin Exp Immunol. 1988;74:404-8.
18. Gleich GJ, Adolphson CR. The eosinophilic leukocyte: structure and function. Adv Immunol. 1986;39:177-253.
19. Weller PF. The immunobiology of eosinophils. N Engl J Med. 1991;324:1110-8.
20. Furuta GT, Ackerman SJ, Wershil BK. The role of the eosinophil in gastrointestinal diseases. Curr Opin Gastroenterol. 1995;11:541-7.
21. Rothenberg ME, Mishra A, Brandt EB, Hogan SP. Gastroeintestinal eosinophils. Inmunol Rev. 2001;179:139-55.
22. Rothenberg ME, Mishra A, Brandt EB, Hogan SP. Gastrointestinal eosinophils in health and disease. Adv Immunol. 2001;78:291-328.
23. Kita H, Adolphson CR, Gleich GJ. Biology of eosinophils. En: Middletown's Allergy, principles and practice Philadelphia, Pennsylvania. Mosby 6th ed, 2003;305-32.
24. Mueller S, Aigner T, Neureiter D, Stolte M. Eosinophil infiltration and degranulation in esophageal mucosa from adult patients with eosinophilic esophagitis (EE). A retrospective comparative pathologic biopsy study. J Clin Pathol. 2006. doi: 10.1136/jcp.2005.031922.
25. Winter HS, Madara JL, Stafford RJ, Grand RJ, Quinlan JE, Goldman H. Intraepitelial eosinophils: a new diagnostic criterion for reflux esophagitis. Gastroenterology. 1982;83:818-23.
26. Brown LF, Goldman H, Antonioli DA. Intraepitelial eosinophils in endoscopic biopsies of adults with reflux esophagitis. Am J Surg Pathol. 1984;8:899-905.
27. Simon D, Marti H, Heer P, Simon HU, Braathen LR, Straumann A. Eosinophilic esophagitis is frequently associated with IgE-mediated allergic airway diseases. J Allergy Clin Inmunol. 2005;115:1090-2.
28. Sgouros SN, Bergele C, Mantides A. Eosinophilic esophagitis in adults: a systematic review. Eur J Gastroenterol Hepatol. 2006;18:211-7.
29. Kelly KJ, Lazenby AJ, Rowe PC, Yardley JH, Perman JA, Sampson HA. Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula. Gastroenterology. 1995;109:03-1512.
30. Liacouras CA. Eosinophilic esophagitis: treatment in 2005. Curr Opin Gastroenterol. 2006;22:147-52.
31. Lucendo Villarín AJ, De Rezende L. Esofagitis eosinofílica: Revisión de los conceptos fisiopatológicos y clínicos actuales. Gastroenterol Hepatol. 2007;30:234-41.
32. Teitelbaum J, Fox V, Twarog F, Nurko S, Antonioli D, Badizadegan K et al. Eosinophilic Esophagitis in Children: inmunopathological analysis and response to fluticasone propionate. Gastroenterology. 2002;122:1226-5.
33. Faubion WA, Perrault J, Burgart LJ, Zein NN, Clawson M, Furuta GT. Treatment of eosinophilic esophagitis with inhaled corticosteroids. J Pediatr Gastroenterol Nutr. 1998;27:90-3.
34. Lucendo AJ, Castillo P, Martín-Chávarri S, Carrión G, Pajares R, Pascual JM et al. Manometric findings in adult eosinophilic oesophagitis: A study of 12 cases. Eur J Gastroenterol Hepatol. 2007;19:417-24.
35. Bullock JZ, Villanueva JM, Blanchard C, Filipovich AH, Putman PE, Collins MH et al, Interplay of adaptive th2 immunity with eotaxin-3/c-C chemokine receptor 3 in eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2007;45:22-31.
36. Straumann A, Bauer M, Fischer B, Blaser K, Simon HU. Idiopathic eosinophilic esophagitis is associated with a T(H)2-type allergic inflamatory response. J Allergy Clin Immunol. 2001;108:954-61.
37. Yamazaki K, Murray JA, Arora AS, Alexander JA, Smyrk TC, Butterfield JH et al. Allergen-specific in vitro cytokine production in adult patients with eosinophilic esophagitis. Dig Dis Sci. 2006;51:1934-41.
38. Gupta SK, Fitzgerald JF, Roudratynk T, Hogenesch H. Cytokine expression in normal and inflamed esophageal mucosa: a study into the pathogenesis of allergic eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2006;42:22-6.
39. Blanchard C, Wang N, Stringer KF, Mishra A, Fulkerson PC, Abonia JP et al. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest. 2006;116:536-47.
40. Lucendo AJ, De Rezende L, Comas C, Caballero MT, Bellón T. Treatment with topic steroids downregulates Il-5, eotaxin-1/CCL11 and eotaxin-3/CCL16 gene expression in eosinophilic esophagitis. (en prensa).
41. Mishra A, Hogan SP, Brandt EB, Rothenberg ME. An etiological role for aeroallergens and eosinophils in experimental esophagitis. J Clin Invest. 2001;107:83-90.
42. Mishra A, Schlotman J, Wang M, Rothenberg ME. Critical role for adaptative T cell immunity in experimental eosinophilic esophagitis in mice. J Leukoc Biol. 2007;81:916-24.
43. Lucendo AJ, Navarro M, Comas C, Letrán A, Pascual Turrión JM, Burgos E et al. Capacidad inmunológica del epitelio esofágico humano: estudio inmunofenotípico mediante estereología aplicado a la esofagitis eosinofílica (abstract). Gastroenterol Hepatol. 2006;29:162.
44. Kirsch R, Bokhary R, Marcon MA, Cutz E. Activated mucosal mast-cells differentiate eosinophilic (allergic) esophagitis from gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr. 2007;44:20-6.
45. Lucendo AJ, Navarro M, Comas C, Pascual JM, Burgos E, Santamaría L et al. Immunophenotypic characterisation and quantification of the epithelial inflammatory infiltrate in eosinophilic esophagitis through stereology: an analysis of the disease's cellular mechanisms and the esophagus's immunological capacity. Am J Surg Pathol. 2007;31:598-606.
46. Rothenberg ME, Mishra A, Collins MH, Putman PE. Pathogenesis and clinical features of eosinophilic esophagitis. J Allergy Clin Inmunol. 2001;108:891-4.
47. Wang HH, Mangano MM, Antonioli A. Evaluation of T-Lynfocites in esophageal mucosal biopsies. Mod Pathol. 1994;7:55-8.
48. Noel RJ, Putman PE, Collins MH, Assa'ad AH, Guajardo JR, Jameson SC et al. Clinical and inmunopathologic effects of swallowed fluticasone for eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2004;2:568-75.
49. Desai TK, Stecevic V, Chang C-H, Goldstein NS, Badizadegan K, Furuta GT. Association of eosinophilic inflamation with esophageal food impactation in adults. Gastrointest Endosc. 2005;61:795-801.
50. Cerf-Bensussan N, Schneeberger EE, Bhan AK. Immunohistologic and immunoelectron microscopic characterization of the mucosal lymphocites of human small intestine by the use of monoclonal antibodies. J Immunol. 1983;130:2615-22.
51. Barner M, Mohrs M, Brombacher F, Kopf M. Differences between IL-4R alpha-deficient mice reveal a role for IL-13 in the regulation of Th2 responses. Curr Biol. 1998;8:669-72.
52. Miyahara N, Swanson B, Takeda K, Taube C, Miyahara S, Kodama T et al. Effector CD8+ T cells mediate inflammation and air way hyper-responsiveness. Nature Med. 2004;10:865-9.
53. Spergel J, Rothenberg ME, Fogg M. Eliminating eosinophilic esophagitis. Clin Inmunol. 2005;115:131-2.
54. Straumann A. The phisiological and pathological roles of eosinophils in the gastrointestinal tract. Allergy. 2004;59:15-25.
55. Weller PF, Lim K, Wan HC, Dvorak AM, Wong DT, Cruikshank WW et al. Role of the eosinophil in allergic reactions. Eur Respir J. 1996;22:109s-15s.
56. Gleich GJ and Kita H. Bronchial astma: lessions from murine models. Proc Natt Acad Sci USA. 1997;94:2101-2.
57. Cieslewicz G, Tomkinson A, Adler A, Duez C, Schwarze J, Takeda K et al. The late, but not early, asthmatic response is dependent on IL-5 and correlates with eosinophil infiltration. J Clin Invest. 1999;104:301-8.
58. Gharaee-Kermani M, McGarry B, Lukacs N, Huffnagle G, Egan RW, Phan SH. The role of IL-5 in bleomycin-induced pulmonary fibrosis. J Leukoc Biol. 1998;64:657-66.
59. Phipps S, Ying S, Wangoo A, Ong YE, Levi-Schaffer F, Kay AB. The relationship between allergen-induced tissue eosinophilia and markers of repair and remodeling in human atopic skin. J Immunol. 2002;169:4604-12.
60. Mishra A, Rothenberg ME. Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism. Gastroenterology. 2003;125:1419-27.
61. Mishra A, Hogan SP, Brandt EB, Rothenberg ME. IL-5 promotes eosinophil trafficking to the esophagus. J Inmunol. 2002;168:2464-9.
62. Akei HS, Mishra A, Blanchard C, Rothenberg ME. Epicutaneous antigen exposure primes for experimental eosinophilic esophagitis in mice. Gastroenterology. 2005;129:985-94.
63. Walsh S, Antonioli D, Goldman H, Fox V, Bousvaros A, Leichtner A et al. Allergic esophagitis in children: a clinicopathologic entity. Am J Surg Pathol. 1999;23:390-6.
64. Bullock JZ, Villanueva JM, Blanchard C, Filipovich AH, Putman PE, Collins MH et al. Interplay of adaptative Th2 immunity with eotaxin-3/C-C Chemokine receptor 3 in eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2007:22-31.
65. Stein ML, Collins MH, Villanueva JM, Kushner JP, Putman PE, Buckmeier BK et al. Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis. J Allergy Clin Immunol. 2006;118:1312-9.
66. Garrett JK, Jameson SC, Thomson B, Collins MH, Wagoner LE, Freese DK et al. Anti-interluekin-5 (mepolizumab) therapy for hipereosinophilic syndromes. J Allergy Clin Inmunol. 2003;113:115-9.
67. Gutierrez Ramos JC, Lloyd C, Gonzalo JA. Eotaxin: from an eosinophilic chemokine to a major regulator of allergic reactions. Immunol Today. 1999;20: 500-4.
68. Mishra A, Hogan SP, Lee JJ, Foster PS, Rothenberg M. Fundamental signals that regulate eosinophil homing to the gastrointestinal tract. J Clin Invest. 1999; 103:1719-27.
69. Rothenberg M, Luster AD, Leder P. Murine eotaxina: an eosinophilchemoattractant inducible in endothelial cells and in interleukin 4-induced tumor supression. Proc Natt Acad Sci USA. 1995;92:8960-4.
70. Zimmermann N, Hogan SP, Mishra A, Brandt EB, Bodette TR, Pope SM et al. Murine eotaxin-2: a constitutive eosinophil chemokine induced by allergen challenge and IL-4 overexpression. J Immunol. 2000;165: 5839-46.
71. Hogan SP, Mishra A, Brandt EB, Royalty MP, Pope SM, Zimmermann N et al. A pathological function for eotaxin and eosinophils in eosinophilic gastrointestinal inflamation. Natur Inmunol. 2001;2:353-60.
72. García-Zepeda EA, Rothenberg ME, Ownbey RT, Celestin J, Leder P, Luster AD. Human eotaxin is a specific chemoattractant for eosinophils cells and provides a new mechanism to explain tissue eosinophilia. Nature Med. 1996;2:449-56.
73. Lamkhioued B, Renzi PM, Abi-Younes S, García-Zepada EA, Allakhverdi Z, Ghaffar O et al. Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation. J Immunol. 1997;159:4593-601.
74. Ying S, Meng Q, Zeibecoglou K, Robinson DS, Macfarlane A, Humbert M. Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3) and MCP-4), and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (intrinsic) asthmatics. J Immunol. 1999;163:6321-9.
75. Fujirawa H, Morita A, Kobayashi H, Hamano K, Fujirawa Y, Hirai K et al. Infiltrating eosinophils and eotaxina: their association with idiopatic eosinophilc esophagitis. Ann Allergy Asthma Immunol. 2005;89:429-32.
76. Kitaura M, Suzuki N, Imai T, Takagi S, Suzuki R, Nakajima T et al. Molecular cloning of a novel human CC chemokine (eotaxin-3) that is a functional ligand of CC chemokine receptor 3. J Biol Chem. 1999;274:27975-80.
77. Kagami S, Saeki H, Komine M, Kakinuma T, Tsunemi Y, Nakamura K et al. Interleukin-4 and interleukin-13 enhances CCL26 production in a human keratinocyte cell line HaCaT cells. Clin Exp Immunol. 2005;141:459-66.
78. Montero Vega MT. New aspects on iflammation in allergic diseases. Allergol et inmunopathol (Madr). 2006; 34:156-79.
79. Coyle AJ, Erard F, Bertrand C, Walti S, Pircher H, Le Gros S. Virus-specific CD8 cells can switch to interleukin 5 production and induce airway eosinophilia. J Exp Med. 1995;181:1229-33.
80. Croft M, Carter L, Swain SL, Dutton RW. Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles. J Exp Med. 1994;180: 1715-28.
81. Seder RA, Boulay JL, Finkelman F, Barbier S, Ben-Sasson ZS, Le Gros G et al. CD8 + T cells can be primed in vitro to produce IL-4. J Immunol. 1992;148: 1652-56.
82. Kimura N, Nakayama T. Differentiation of NK1 and NK2 cells. Crit Rev Immunol. 2005;25:361-74.
83. Wei H, Zhang J, Xiao W, Feng J, Sun R, Tian Z. Involvement of human natural killer cells in asthma pathogenesis: natural killer 2 cells in type 2 cytokine predominance. J Allergy Clin Immunol. 2005;115:842-7.
84. Meresse B, Curran SA, Ciszewski C, Orbelyan G, Setti M, Bhagat G et al. Reprogramming of CTLs into natural killer-like cells in celiac disease. J Exp Med. 2006;203:1343-55.
85. Foti M, Granucci F, Ricciardi-Castagnoli P. Dendritic cell interactions and cytokine production. Ernst Schering Res Found Workshop. 2006;(56):61-80.
86. Katz SI, Tamaki K, Sachs DH. Epitelial Langerhans cells originating in bone marrow. Nature. 1979;282:324-6.
87. Perrault C, Pelletier M, Landry D, Gyner M. Study of langerhans cells after allogenic bone marrow transplantation. Blood. 1984;63:807-11.
88. De Fraissinette A, Schmitt D, Thivolet J. Langerhans cells of human mucosa. J Dermatol. 1989;16:255-62.
89. Al Yassin TM, Toner PG. Langerhans cells in the human oesophagus. J Anat. 1976;122:435-45.
90. Geboes K, De Wolf-Peeters C, Rutgeerts P, Janssens J, Vantrappen G, Desmet V. Lymphocytes and Langerhans cells in the human oesophageal epithelium. Virchows Arch A Pathol Anat. 1983;401:45-55.
91. Terris B, Potet F. Structure and role of Langerhans'cells in the human oesophageal epithelium. Digestion. 1995;56(suppl):9-14.
92. Gielen V, Schmitt D, Thivolet J. HLA class I antigen (heavy and light chain) expression by langerhans cells and keratinocytes of the normal human epidermis: Ultrastructural quantitaion using immunogold labeling. Arch Dermatol Res. 1988;280:131-6.
93. Murphy GF, Bhan AK, Sato S, Mihm MC, Harrist TJ. A new immunologic marker for human Langerhans cells. N Engl J Med. 1981;304:791-2.
94. Teunissen MBM. Dynamic nature and function of epidermal Langerhans cells in vivo and in vitro: a review, with emphasis on human Langerhans cells. Histochem J. 1992;24:697-716.
95. Sontheimer RD, Stastny P, Nunez G. HLA-D region expression by human epidermal Langerhans cells. J Invest Dermatol. 1986;87:707-10.
96. Rowden G. Expression of Ia antigen on Langerhans cells in mice, guinea pIgAnd man. J Invest Dermatol. 1980;75:22-31.
97. Steinman RM, Nussenzmeig MC. Dendritic cells: Features and function. Immunol Rev. 1980;53:127-47.
98. Krishnaswamy G, Ajitawi O, Chi DS. The human mast cell: an overview. Methods Mol Biol. 2006;315:13-34.
99. Zheutlin LM, Ackerman SJ, Gleich GJ. Stimulation of basophil and mast cells histamine release by eosinophil granule-derived cationic proteins. J Immunol. 1984;133:2180-5.
100. Metcalfe DD, Baram D, Mekory YA. Mast cells. Physiol Rev. 1997;77:1033-79.
101. Jutel M, Blaser K, Akdis CA. The role of histamine in regulation of immune responses. Chem Immunol Allergy. 2006;91:174-87.
102. Akdis CA, Blaser K. Histamine in the immune regulation of allergic inflammation. J Allergy Clin Immunol. 2003;112:15-22.
103. Sayed BA, Brown MA. Mast cells as modulators of T-cell responses. Immunol Rev. 2007;217:53-64.
104. Kinet JP. The essential role of mast cells in orchestating inflammation. Immunol Rev. 2007;217:5-7.
105. Kumar R, Sentongo T, Nelson SP, Melin-Aldana H, Li BUK. Eosinophilic esopahgitis in children. a review. Clin Applied Inmunol Rev. 2003;4:173-88.
106. Justinich CJ, Kalafus D, Esposito P, Ricci Jr A, Sylvester FA, Hyams JS et al. Mucosal mast cells distinguish allergic from gastroesophageal reflux-induced esophagitis. J Pediatr Gastroenterol Nutr. 1996;23:342A.
107. Moots RJ, Prouse P, Gumpel JM. Near fatal eosinophilic gastroenteritis responded to oral sodium cromoglycate. Gut. 1988;29:1282-5.
108. Businco L, Cantani A. Food allergy in children: diagnosis and treatment with sodium cromoglycate. Allergol Inmunopathol (Madr). 1990;18:339-48.
109. Mann NS, Leung JW. Pathogenesis of esophageal ring in eosinophilic esophagitis. Med Hypotheses. 2005;64:520-3.
110. Liacouras CA, Bonis P, Putman PE, Straumann A, Ruchelli E, Gupta SK et al. Summary of the First International Gastrointestestinal Eosinophil Research Symposium. J Pediatr Gastroenterol Nutr. 2007;45:370-91.
111. Vanderhoff JA, Young RJ. Allergic disorders of the gastrointestinal tract. Curr Opin Clin Nutr Metab Care. 2001;4:553-6.
112. Cheung KM, Oliver MR, Vameron DJS, Catto-Smith AG, Chow CW. Esophageal eosinophilia in children with dysphagia. J Pediatr Gastroenterol Nutr. 2003;37:498-503.
113. Barclay RL, Dinda PK, Morris GP, Paterson WG. Morphological evidence of mast cell degranulation in an animal model of acid-induced esophageal mucosal injury. Dig Dis Sci. 1995;40:1651-8.
114. Feldman MJ, Morris GP, Dinda PK, Paterson WG. Mast cells mediate acid-induced augmentation of opossum esophageal blood flow via histamine and nitric oxide. Gastroenterology. 1996;110:121-8.
115. Fox VL, Nurko S, Furuta GT. Eosinophilic esophagitis: It's not just kid's stuff. Gastrointest Endosc. 2002;56: 260-70.
116. Martín-Muñoz MF, Lucendo AJ, Navarro M, Letrán A, Martín-Chávarri S, Burgos E et al. Food allergy and eosinophilic esophagitis: two cases studies. Digestion. 2006;74:49-54.
117. Butterworth AE. The eosinophil and its role in immunity to helminth infection. Curr Top Microbiol Immunol. 1997;77:127-68.
118. Butterworth AE. Cell-mediated damage to helminths. Adv Parasitol. 1984;23:143-235.
119. Lucey DR, Nicholson WA, Weller PF. Mature human eosinophils have the capacity to express HLA-DR. Proc Natt Acad Sci USA. 1989;86:1348-51.
120. Ohkawara Y, Lim KG, Xing Z, Glibetic M, Nakano K, Dolovich J et al. CD40 expression by human peripheral blood eosinophils. J Clin Invest. 1996;97:1761-6.
121. Woerly G, Roger N, Loiseau S, Dombrowicz D, Capron A, Capron M. Expression of CD28 and CD 86 by human eosinophils and role in the secretion of type 1 cytokines (interleukin 2 and interferon gamma) by immunoglobulin A complexes. J Exp Med. 1990;190:487-96.
122. Kita H. The eosinophil: a citokine producing cell? J Allergy Clin Immunol. 1996;97:889-92.
123. Dahms BB. Reflux esophagitis: sequelae and dufferential diagnosis in infants and children including eosinophilic esophagitis. Pediatr Develop Pathol. 2004;17:5-16.
124. Lucendo Villarín AJ, Carrión Alonso G, Navarro Sánchez M, Martín Chávarri S, Gómez Senent S, Castillo Grau P et al. Eosinophilic eosinophilic in adults, an emerging cause of dysphagia. Description of 9 cases. Rev Esp Enf Dig. 2005;97:229-39.
125. Lucendo AJ, Pascual-Turrión JM, Navarro M, Comas C, Castillo P, Letrán A et al. Endoscopic, bioptic and manometric findings in eosinophilic esophagits before and after steroid therapy: a case series. Endoscopy. 2007;39:765-71.
126. Lucendo AJ. Motor disturbances participate in the pathogenesis of eosinophilic oesophagistis, beyond the fibrous remodelling of the oesophagus. Aliment Pharmacol Ther. 2006;24:1264-7.
127. Aceves SS, Newbury RO, Dohil R, Bastian JF, Broide DH. Esophageal remodeling in paediatric eosinophilic esophagitis. J Allergy Clin Immunol. 2007;119:206-12.
128. Chehade M, Sampson HA, Morotti RA, Magid MS. Esophageal subepithelial fibrosis in children with eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2007;45:319-28.
129. Bousquet J, Vignola AM, Demoly P. Links between rhinitis and asthma. Allergy. 2003;58:691-706.
130. Simon D, Vassina E, Yousefi S, Kozlowski E, Braathen L, Simon HU. Reduced dermal infiltration of cytokine-expressing cells in atopic dermatitis following short term topical tacrolimus treatment. J Allergy Clin Immunol. 2004;114:887-95.
131. Bishop WP, Haber BA, Lichtman SN, Shneider BL. Learning more about eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2002;35:711-2.
132. Word LJ, Sehmi R, Dorman S, Hamid Q, Tulic MK, Watson RM et al. Allergen-induced increases in bone marrow T lymphocytes and interleukin-5 expression in subjects with asthma. Am J Respir Crit Care Med. 2002;166:883-9.
133. Lake AM. Allergic bowel disease. Adolesc Med Clin. 2004;15:105-17.
134. Fogg MI, Ruchelli E, Spergel JM. Pollen and eosinophilic esophagitis. J Allergy Clin Inmunol. 2003;112:796-7.
135. Onbasi K, Sin Az, Doganavsalgil B, Onder GF, Bor S, Sebik F. Eosinophil infiltration of the esophageal mucosa in patients with pollen allergy during the season. Clin Exp Allergy. 2005;35:1423-31.
136. Wang FY, Gupta SK, Fitzgerald JF. Is there a seasonal variation in the incidence or intensity of allergic eosinophilic esophagitis in new diagnosed children? J Clin Gastroenterol. 2007;41:451-3.
137. Spergel JM, Mizoguchi E, Brewer JP, Martin TR, Bhan AK, Geha RS. Epicutaneous sensibilization with protein antigen induces localizad allergic dermatitis and hiperresponsiveness to methacoline alter single exposure to aeroalergen in mice. J Clin Invest. 1998;101:1614-22.
138. Plaza-Martín AM, Jiménez-Feijoo R, Andaluz C, Giner-Muñoz MT, Martín-Mateos MA, Piquer-Gibert M et al. Polysensitization to aeroallergens and food in eosinophilic esophagitis in a pediatric population. Allergol et Inmunopathol. 2007;35:35-7.
139. Spergel JM, Beausoleil JL, Mascarenhas M, Liacouras CA. The use of skin prick tests and patch tests to identify causative foods in eosinophilic esophagitis. J Allergy Clin Inmunol. 2002;109:363-8.
140. Sicherer. Clinical aspects of gastrointestinal food allergy in childhood. Pediatrics. 2003;111:1609-16.
141. American Gastroenterological Association medical position statement: guidelines for the evaluation of food allergies. Gastroenterology. 2001;120:1023-5.
142. Hill DJ, Heine RG, Hosking CA. The diagnostic value of skin prick test in food allergy. Pediatr Allergy Immunol. 2004;15:435-41.
143. Spergel JM, Andrews T, Brown-Whitehorn TF, Beausoleil JL, Liacouras CA. Treatment of eosinophilic esophagitis with specific elimination diet directed by a combination of skin prick and patch test. Ann Allergy Asthma Immunol. 2005;95:336-43.
144. Bohle B. T lymphocytes and food allergy. Mol Nutr Food Res. 2004;48:424-33.
145. Hong SJ, Michael JG, Fehringer A, Leung DY. Pepsin-digested peanut contains T-cell epitopes but not IgE epitopes. J Allergy Clin Immunol. 1999;104:473-8.
146. Haselden BM, Kay AB, Larche M. Immunoglobulin E-independent major histocompatibility complex-restricted T cell peptide epitope-induced lata asthmatic reactions. J Exp Med. 1999;189:1885-94.
147. Smith TR, Larche M. Investiganting T cell activation and tolerance in vivo: peptide challenge in allergic asthmatics. Cytokine. 2004;28:49-54.
148. Sampson HA. Update in food allergy. J Allergy Clin Immunol. 2004;113:813-9.
149. Leung DY, Bieber T. Atopic dermatitis. Lancet. 2003;361:151-60.
150. Spergel JM, Brown-Whitehorn T. The use of patch testing in the diagnosis of food allergy. Curr Allergy Asthma Rep. 2005;5:86-90.
151. Assa'ad A. Detection of causative foods by skin prick and atopy patch test in patients with eosinophilic esophagitis: things are not what they seem. Ann Allergy Asthma Immunol. 2005;95:309-11.